Table 2.
Clinicopathologic characteristics of patients who underwent CRS ± HIPEC
| Age | Histology | Chemo | PCI | PIPAC (n) | Type of surgery | HIPEC | R status | pTNM | TRG | Complications (CD) | Status | Survival (days) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65 | Signet | FLOT | 8 | 1 | GT | Yes | R0 | ypT0N0M0 | 1 | I | Alive | 881 |
| 54 | Signet | FOLFOX | 3 | 2 | GT + colic and jejunal resection | Yes | R0 | ypT4aN3M1 | 5 | IIIa | Death | 250 |
| 49 | Signet | FOLFOX | 4 | 2 | GT +colic resection, bilateral ovariectomy | Yes | R1 | ypT4aN3M1 | 5 | IIIa | Death | 457 |
| 67 | Signet | FLOT | 4 | 1 | GT | No | R0 | ypT1bN3M1 | 3 | IIIa | Death | 232 |
| 57 | Signet | FOLFOX | 2 | 3 | GT | No | R0 | ypT3N0M0 | 2 | – | Alive | 696 |
| 43 | Signet | FOLFOX | 26 | 2 | GT + bilateral ovariectomy | Yes | R0 | ypT2N0M1 | 3 | II | Death | 916 |
| 64 | Mucinous | FOLFOX | 6 | 2 | GT | Yes | R0 | ypT4N3M0 | 3 | I | Alive | 365 |
| 48 | Mixed | DOX | 10 | 2 | GT + bilateral ovariectomy | Yes | R0 | ypT0N0M0 | 1 | II | Alive | 963 |
| 56 | Tubular | FLOT | 12 | 1 | Ivor–Lewis esophagectomy | No | R0 | ypT0N0M0 | 1 | IIIa | Death | 554 |
| 63 | Signet | FLOT | 6 | 1 | GT | Yes | R1 | ypT4aN1M1 | 2 | II | Alive | 719 |
| 71 | Tubular | DOX | 3 | 1 | GT + spleen and left adrenal gland resection | Yes | R0 | ypT4aN1M0 | 3 | IIIa | Alive | 326 |
CRS cytoreductive surgery, HIPEC hyperthermic intraperitoneal chemotherapy, Chemo chemotherapy, PCI Peritoneal Cancer Index, PIPAC pressurized intraperitoneal aerosol chemotherapy, TRG tumor regression grade, CD Clavien–Dindo, FLOT fluorouracil, leucovorin, oxaliplatin and docetaxel, FOLFOX folinic acid, fluorouracil and oxaliplatin, DOX doxorubicin